📰 Simcere Pharmaceuticals News
Simcere Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Simcere Pharmaceuticals. Real-time updates on events, politics, business and more.
February 9, 2024
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The
February 7, 2024
/PRNewswire/ -- The "Global Genome Editing Market, 2023-2035: Focus on Technology, Industry Trends and Forecasts" report has been added to...
April 20, 2023
Dublin, April 20, 2023 (GLOBE NEWSWIRE) -- The "Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics...
November 18, 2022
Idorsia entered into a licensing agreement in China for Idorsia's daridorexant, an orexin antagonist medication used for insomnia.
October 14, 2022
Check out new developments from Memory Health, Carrum Health, Carmine Therapeutics and Alleva.
October 13, 2022
/PRNewswire/ -- Carmine Therapeutics ("Carmine"), an EVX founded biotech company and emerging leader in non-viral gene therapies, today announced the first...
October 13, 2022
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
February 8, 2022
/PRNewswire/ -- Simcere is thrilled to announce Bijoyesh Mookerjee, M.D., as our Chief Medical Officer, Oncology, of Simcere Pharmaceutical Group. Bijoyesh...
February 8, 2022
/PRNewswire/ -- Simcere is thrilled to announce Bijoyesh Mookerjee, M.D., as our Chief Medical Officer, Oncology, of Simcere Pharmaceutical Group. Bijoyesh...
December 3, 2021
DUBLIN--(BUSINESS WIRE)--The "Global Biosimilars Partnering Terms and Agreements 2010 to 2021" report has been added to ResearchAndMarkets.com's offering.The Global Biosimilars Partnering Terms and Agreements 2010 to 2021 report provides an understanding and access to the Biosimilars partnering deals and agreements...